Xanthinuria Markers – Diagnosis and Lab Values

What Are Xanthinuria Markers?

Xanthinuria markers are laboratory diagnostic indicators used to detect and monitor xanthinuria, a rare inherited metabolic disorder affecting the breakdown of purines. In this condition, xanthine accumulates in the blood and urine because the enzyme responsible for its further metabolism is deficient or absent. Specific laboratory values serve as markers for this disease and allow for a targeted diagnosis.

Background: What Is Xanthinuria?

Xanthine is an intermediate product in purine metabolism that is normally converted to uric acid by the enzyme xanthine oxidase. In xanthinuria, this enzyme is defective or completely absent, preventing xanthine from being further metabolized. There are two main types:

• Type I: Isolated xanthine oxidase deficiency
• Type II: Combined deficiency of xanthine oxidase and aldehyde oxidase

In rare cases, a molybdenum cofactor deficiency (Type III) may also be present, affecting additional enzymes in the pathway.

Which Markers Are Measured?

Xanthine in Urine (Primary Diagnostic Marker)

The most important diagnostic marker is an elevated xanthine concentration in the urine. Under normal conditions, xanthine is present in the urine only in very small amounts. In xanthinuria, levels are significantly elevated and can be measured using HPLC (high-performance liquid chromatography) or mass spectrometry.

Uric Acid in Serum and Urine

A hallmark finding in xanthinuria is a very low uric acid concentration in the blood serum (hypouricemia) and reduced urinary uric acid excretion. This finding is an important indicator and should always prompt consideration of xanthinuria when unexplained hypouricemia is observed.

Hypoxanthine in Urine

In addition to xanthine, hypoxanthine levels in the urine may also be elevated, as both substances accumulate as substrates of xanthine oxidase.

Enzyme Activity Measurement

In specialized laboratories, the activity of xanthine oxidase can be measured in intestinal biopsy samples or liver tissue. An absent or strongly reduced enzyme level confirms the diagnosis.

Molecular Genetic Markers

Through genetic analysis, mutations in the genes XDH (xanthine dehydrogenase/xanthine oxidase) or MOCOS (molybdenum cofactor sulfurase) can be identified. These molecular genetic markers allow definitive classification of the disease type and are especially valuable for family screening.

Clinical Relevance of the Markers

Xanthinuria markers are clinically significant because the condition often follows an asymptomatic course but can lead to serious complications, including:

• Xanthine kidney stones (nephrolithiasis) and urinary tract calculi
• Myopathy (muscle weakness) caused by xanthine deposits in muscle tissue
• Arthropathy due to xanthine crystals in the joints

Early detection through the appropriate markers allows complications to be prevented through dietary measures such as a low-purine diet and adequate fluid intake.

Diagnosis and Workup

The diagnostic process when xanthinuria is suspected typically includes the following steps:

• Measurement of serum uric acid (reduced in xanthinuria)
• Quantitative measurement of xanthine and hypoxanthine in 24-hour urine
• Extended purine analysis using HPLC or LC-MS/MS
• If results are positive: enzyme activity assay and/or molecular genetic testing

References

1. Reiter S, Simmonds HA, Zöllner N et al. - Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuria type II. Clinica Chimica Acta, 1990.
2. Ichida K, Amaya Y, Kamatani N et al. - Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. Journal of Clinical Investigation, 1997.
3. Garrod AE - Inborn Errors of Metabolism. Oxford University Press, 2nd edition, 1923 (landmark reference in metabolic genetics).